PMID- 37155616
OWN - NLM
STAT- MEDLINE
DCOM- 20230810
LR  - 20230810
IS  - 1557-9034 (Electronic)
IS  - 1092-6429 (Linking)
VI  - 33
IP  - 8
DP  - 2023 Aug
TI  - Comparison of Laparoscopic Sleeve Gastrectomy and Single Anastomosis Sleeve Ileal 
      Bypass in Type 2 Diabetes Mellitus Remission Using International Criteria.
PG  - 768-775
LID - 10.1089/lap.2023.0112 [doi]
AB  - Introduction: Single anastomosis sleeve ileal (SASI) bypass procedure is 
      recommended in the treatment of patients with obesity, who have comorbidities 
      such as type 2 diabetes mellitus (T2DM). Meanwhile, laparoscopic sleeve 
      gastrectomy (LSG) has become the most preferred contemporary bariatric procedure. 
      Research comparing these two techniques are scarce in the literature. In this 
      study, we aimed to compare LSG and SASI procedures in terms of weight loss and 
      diabetes remission. Materials and Methods: Thirty patients, who underwent LSG and 
      31 patients, who underwent SASI, with a body mass index (BMI) of 35 and above, 
      and under unsuccessful medical treatment, in terms of T2DM, were included in the 
      study. Patients' demographic data were recorded. Oral antidiabetic drugs and 
      insulin use, HbA1c and fasting blood glucose values, and BMI values were recorded 
      preoperatively, at thd sixth month and at first year. According to these data, 
      patients were compared in terms of primarily diabetes remission and secondarily 
      weight loss. Results: At the sixth month and first year, the mean excess weight 
      loss (EWL) values of the SASI group were 55.2% +/- 12.45% and 71.67% +/- 15.75%, 
      respectively, while EWL values of the LSG group were 57.41% +/- 16.22% and 
      69.73% +/- 16.65%, respectively (P > .05). T2DM evaluations revealed that in the 
      SASI group, 25 (80.65%) patients at the sixth month and 26 (83.87%) patients at 
      the first year had either clinical improvement or remission, whereas 23 (76.67%) 
      patients at the sixth month and 26 (86,67%) patients at the first year in the LSG 
      group had the same outcomes (P > .05). Conclusion: The short-term comparison of 
      LSG and SASI procedures revealed similar results in terms of weight loss and T2DM 
      remission. Hence, LSG can be considered as the first-step treatment of morbid 
      obesity accompanied by T2DM, since it is a simpler surgical procedure.
FAU - Yildirak, Muhammed Kadir
AU  - Yildirak MK
AUID- ORCID: 0000-0002-6241-5661
AD  - Department of General Surgery, Umraniye Training and Research Hospital, 
      University of Health Sciences, Istanbul, Turkey.
FAU - Sisik, Abdullah
AU  - Sisik A
AUID- ORCID: 0000-0002-7500-8651
AD  - Department of General Surgery, Dr. HE Obesity Clinic, Istanbul, Turkey.
FAU - Demirpolat, Muhammed Taha
AU  - Demirpolat MT
AUID- ORCID: 0000-0002-3772-610X
AD  - Department of General Surgery, Umraniye Training and Research Hospital, 
      University of Health Sciences, Istanbul, Turkey.
LA  - eng
PT  - Journal Article
DEP - 20230508
PL  - United States
TA  - J Laparoendosc Adv Surg Tech A
JT  - Journal of laparoendoscopic & advanced surgical techniques. Part A
JID - 9706293
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/complications/surgery
MH  - Treatment Outcome
MH  - *Laparoscopy/methods
MH  - *Obesity, Morbid/surgery/complications
MH  - Anastomosis, Surgical
MH  - Gastrectomy/methods
MH  - Weight Loss
MH  - *Gastric Bypass/methods
MH  - Retrospective Studies
OTO - NOTNLM
OT  - laparoscopic sleeve gastrectomy
OT  - single anastomosis sleeve ileal bypass
OT  - type 2 diabetes mellitus
EDAT- 2023/05/08 18:42
MHDA- 2023/08/10 06:43
CRDT- 2023/05/08 14:13
PHST- 2023/08/10 06:43 [medline]
PHST- 2023/05/08 18:42 [pubmed]
PHST- 2023/05/08 14:13 [entrez]
AID - 10.1089/lap.2023.0112 [doi]
PST - ppublish
SO  - J Laparoendosc Adv Surg Tech A. 2023 Aug;33(8):768-775. doi: 
      10.1089/lap.2023.0112. Epub 2023 May 8.